| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/27/1992 | CN1061341A Use of thiazoloisoindolinone derivatives as antiviral medicaments |
| 05/27/1992 | CN1061340A Semduramicin premix |
| 05/27/1992 | CN1016785B Azithromycin dihydrate |
| 05/27/1992 | CA2096943A1 Oral spiramycine formulations and method for preparing same |
| 05/26/1992 | US5116964 Hybrid immunoglobulins |
| 05/26/1992 | US5116960 Amphotericin b derivatives |
| 05/26/1992 | US5116871 Fatty acid therapy and compositions for the treatment of myalgic encephalomyelitis |
| 05/26/1992 | US5116844 Triazole antifungal agents |
| 05/26/1992 | US5116835 Enzyme-inhibiting urea derivatives of dipeptides, a process for the preparation thereof, agents containing these, and the use thereof |
| 05/26/1992 | US5116833 Antibiotic c-3 dithioacetal-substituted carbapenem compounds, compositions, and methods of use thereof |
| 05/26/1992 | US5116832 Penem derivatives production and use thereof |
| 05/26/1992 | US5116603 Oral antifungal preventative, and method of use |
| 05/26/1992 | CA1301760C Pyridonecarboxylic acid derivatives having 3-[amino(alkyl)methyl]-pyrrolidine |
| 05/26/1992 | CA1301689C Method for selectively increasing the ratio of single major components ofantibiotic a 16686 complex |
| 05/22/1992 | WO1992009203A1 Tnf inhibitors |
| 05/22/1992 | CA2096623A1 Tnf inhibitors |
| 05/21/1992 | WO1992008729A1 Antisense nucleic acid derivative |
| 05/21/1992 | DE4036571A1 Verwendung von 2h-1,2,4-benzothiadiazin-3(4h)-thion-1,1- dioxiden als antivirale arzneimittel Use of 2H-1,2,4-benzothiadiazine-3 (4H) -thione-1,1-dioxides as antiviral drugs |
| 05/21/1992 | CA2096658A1 Anti-sense nucleic acid derivative |
| 05/21/1992 | CA2096633A1 Measles virus recombinant poxvirus vaccine |
| 05/20/1992 | EP0486477A2 1-( -D-Arabinofuranosyl)-5-propynyluracil as a VZV-antiviral compound |
| 05/20/1992 | EP0486106A2 Marek's disease virus vaccine |
| 05/20/1992 | EP0486045A2 S(+)-Phenyl-alkanoic acids and alpha-amino acid containing complexes |
| 05/20/1992 | EP0486011A2 Pharmaceutical composition against Pneumocystis carinii |
| 05/20/1992 | EP0485890A2 Use of 2,3-disubstituate 1-azolyl-propane for inhibiting the pathogenic growth phase of dimorph yeast cell |
| 05/20/1992 | EP0485808A2 Antibiotic C-3 catechol-substituted cephalosporin compounds, compositions and use thereof |
| 05/20/1992 | EP0485430A1 Methods and compositions for ameliorating the symptoms of sepsis |
| 05/20/1992 | EP0485407A1 Proteins with tnf activity |
| 05/20/1992 | EP0437556A4 Substitution analogues of magainin peptides |
| 05/20/1992 | EP0428707A4 Steroid modified oligonucleotides |
| 05/20/1992 | EP0347448B1 Aqueous preparation based on mineral salts and acetic acid for the prevention and treatment of viral diseases |
| 05/20/1992 | CN1016663B Pig feed |
| 05/20/1992 | CA2055685A1 Hiv protease inhibitors having polyether substituents |
| 05/19/1992 | US5115098 End-blocked peptides inhibiting binding capacity of gp120 |
| 05/19/1992 | US5114967 Antibiotic alisamycin and its use |
| 05/19/1992 | US5114933 Cephalosporin compounds |
| 05/19/1992 | US5114711 Covalently linked polypeptide cell modulators such as interferon-lymphotoxin conjugates |
| 05/17/1992 | WO1992008786A1 Human rotaviruses, vaccines and methods |
| 05/17/1992 | WO1992008462A1 Use of 2h-1,2,4-benzothiadiazine-3(4h)-thion-1,1-dioxides as antiviral medicaments |
| 05/17/1992 | WO1992008373A1 Semduramicin premix |
| 05/17/1992 | CA2096239A1 Use of 2h-1,2,4-benzothiadiazine-3(4h)-thione 1,1-dioxides as antiviral medicaments |
| 05/16/1992 | CA2055683A1 Complexes containing s(+) phenyl alkane acids and .alpha.-amino acids |
| 05/16/1992 | CA2055682A1 Complexes containing s(+) phenyl alkane acids and -hydroxyalkane acids |
| 05/15/1992 | WO1992008461A1 Specific inhibition of dihydrofolate reductase and compounds therefor |
| 05/15/1992 | CA2095539A1 Diagnosis and treatment of multiple sclerosis |
| 05/15/1992 | CA2095518A1 Specific inhibition of dihydrofolate reductase and compounds therefor |
| 05/14/1992 | WO1992008485A1 Diagnostic testing for campylobacter jejuni or coli infection using antigens |
| 05/14/1992 | WO1992007941A1 Assembled viral particles and their use in a vaccine to rotaviral disease |
| 05/14/1992 | WO1992007938A1 Cell growth inhibitors |
| 05/14/1992 | WO1992007920A1 Improved processes for the manufacture of enriched pitches and carbon fibers |
| 05/14/1992 | WO1992007871A1 Peptide-based inhibitors of hiv replication |
| 05/14/1992 | WO1992007578A1 Use of protective agents against reactive oxygen species |
| 05/14/1992 | WO1992007575A1 Antimicrobial composition |
| 05/14/1992 | WO1992007570A1 Agents for the treatment of diseases caused by parasitic protozoa and neoplastic diseases |
| 05/14/1992 | WO1992007565A1 Sampangine and derivatives useful as antifungal agents |
| 05/14/1992 | WO1992007564A2 Method of treating demyelinating disease |
| 05/14/1992 | WO1992007465A1 Microbiocidal combinations of materials and their use |
| 05/14/1992 | WO1991018984A3 New antifungal preparations, process for making such preparations, process for obtaining plants with decreased susceptibility to fungi |
| 05/14/1992 | DE4035809A1 Verwendung von thiazoloisoindolinon-derivaten als antivirale arzneimittel Use of thiazoloisoindolinon derivatives as antiviral drug |
| 05/14/1992 | CA2096016A1 Diagnostic testing for campylobacter jejuni or coli injection using antigens |
| 05/14/1992 | CA2094916A1 Assembled viral particles and their use in a vaccine to rotaviral disease |
| 05/14/1992 | CA2092075A1 Peptide-based inhibitors of hiv replication |
| 05/14/1992 | CA2054958A1 Antibiotic c-3 catechol-substituted cephalosporin compounds, compositions and method of use thereof |
| 05/13/1992 | EP0484966A2 7-Acyl-3-(substituted carbamoyloxy) cephem compounds, use thereof and process for their preparation |
| 05/13/1992 | EP0484936A1 Suspensions containing tricyclic compounds |
| 05/13/1992 | EP0484881A2 Heteroaroyl derivatives of monocyclic beta-lactam antibiotics |
| 05/13/1992 | EP0484856A2 Dynemicin C antitumor antibiotic |
| 05/13/1992 | EP0484785A2 Use of xanthines for the preparation of a medicament effective for inhibiting the replication of human retroviruses |
| 05/13/1992 | EP0484621A2 Efficacious vaccines against Bordetella pertussis comprising a combination of individually purified pertussis antigens |
| 05/13/1992 | EP0484403A1 Lipid a analog/immunogenic carrier conjugates and the use thereof as vaccines |
| 05/13/1992 | EP0429645A4 Reducing the spread of infection by blood handling equipment |
| 05/13/1992 | CN1016607B Method for preparing crystalline cefadroxil monoltyrate |
| 05/12/1992 | US5112967 Process for synthesizing antibacterial cephalosporin compounds |
| 05/12/1992 | US5112963 Modified oligonucleotides |
| 05/12/1992 | US5112858 Antitumor agent |
| 05/12/1992 | US5112844 Micelles |
| 05/12/1992 | US5112806 Antibiotic, mersacidin, a process for the preparation thereof and the use thereof as a pharmaceutical |
| 05/12/1992 | CA1300622C Anti-viral compounds |
| 05/12/1992 | CA1300604C Methoxymethyl compounds |
| 05/12/1992 | CA1300603C Process for the conversion of the e-isomer of 6-(substituted methylene)-2-penems into the z-isomer |
| 05/12/1992 | CA1300536C Process for antifungal fermentation product and culture |
| 05/11/1992 | WO1992008457A1 Use of thiazolo-isoindolinone derivatives as antiviral medicaments |
| 05/11/1992 | CA2095249A1 Use of thiazoloisoindolinone derivatives as antiviral medicaments |
| 05/10/1992 | WO1992008495A1 Cytokine immunoconjugates |
| 05/10/1992 | WO1992004342A1 A novel quinolone carboxylic acid derivative |
| 05/09/1992 | WO1992008488A1 Mycobacterium as adjuvant for antigens |
| 05/09/1992 | CA2054983A1 Suspendible composition and process for preparing the same |
| 05/08/1992 | WO1992008456A2 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated |
| 05/08/1992 | CA2095732A1 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated |
| 05/08/1992 | CA2055041A1 Use of xanthines for the preparation of a medicament effective for inhibiting the replication of human retroviruses |
| 05/07/1992 | WO1992007579A1 Soluble mannose receptor peptides |
| 05/07/1992 | CA2095729A1 Soluble mannose receptor peptides |
| 05/06/1992 | EP0484281A2 Cyclosporins |
| 05/06/1992 | EP0484112A2 Use of lithium in the treatment or prophylaxis of Molluscum contagiosum |
| 05/06/1992 | EP0484071A2 Synergism of HIV reverse transcriptase inhibitors |
| 05/06/1992 | EP0484030A2 Antibiotic C-3 cyclobutenedione substituted (1-carba)cephalosporin compounds, compositions, and methods of use thereof |
| 05/06/1992 | EP0483634A2 An aminoglycoside composition having substantially reduced nephrotoxicity induced by the amino glycoside |
| 05/06/1992 | EP0483271A1 Peptides containing diamino-glycols as transition-state mimics. |
| 05/06/1992 | EP0299082B1 Antiviral agent |
| 05/06/1992 | CN1060847A Tylosin derivative and method for preparing same |